Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: ip
Ariosa v. Sequenom – Rehearing En Banc Denied
Not surprisingly, the Fed. Cir., on December 2nd, denied Sequenom’s petition for rehearing en banc of the invalidation of certain of the claims of U.S. Pat. No. 6,258,540 which were directed to methods of detecting and using cffDNA. (Appeal no. … Continue reading
Prometheus v. Roxane – A Glimpse of Christmas Future?
A Fed. Cir. panel of Judges Dyk, Taranto and Hughes affirmed the district court’s invalidation of a Prometheus “add-on” patent (U.S. Pat. No. 6,284,770) to a method to treat a form of irritable bowel syndrome, IBS-D, with alosetron, as obvious … Continue reading
Australian Patent Office Proposes “Coding Only” Sequence Ban
Coming soon after the High Court’s “Myriad decision” in Australia, the Australian Patent Office has proposed guidelines that would effectively limit the ban on patent-eligibility of DNA sequences to nucleic acids that code for polypeptides. While cDNA is still considered … Continue reading
Janice Mueller’s New Article: Patent -Ineligible Methods of Treatment
Patent-Ineligible Methods of Treatment Janice M. Mueller Chisum Patent Academy October 3, 2015 Janice M. Mueller, Patent-Ineligible Methods of Treatment, in MUELLER ON PATENT LAW, VOL. I (PATENTABILITY AND VALIDITY) (Wolters Kluwer Law & Business 2012), last revised October 2015 … Continue reading